TYME-19

N/A

Report date: 2021/12/15 10:24:28
NME

Base Information

Drug NameTYME-19
Drug Alias NameTYME-19
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acids replacementsVirus replication inhibitors
TargetsBile acids
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSyros Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSyros Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A